Jennifer Lawrence has signed on to play Theranos owner Elizabeth Holmes in the new Adam McKay movie.
Jennifer Lawrence has just finished a major milestone in her life. She has successfully completed two film franchises. The release of X Men Apocalypse marked the end of the final movie that Jen had signed in a franchise deal.
Don't Miss: Nintendo Switch: Everything You Need To Know
There was debate about what she will be doing once her scheduled cleared for a little while. Many reckoned that the actress would take a well-deserved break. In an interview, Jen said that this was the prime time of her life when she could work. She said that she will try to take on projects that were good and allowed her to fill her schedule. Independent film makers are approaching the star as her schedule has cleared.
She is currently scheduled to appear in the main role in Morten Tyldum’s Passengers alongside Chris Pratt. She has also signed on to play a part in Sony’s Marita where she will play the lead role. She has an untitled film directed by Darren Aronofsky in the works with Scott Franklin and Ari Handel of Protozoa producing. She is rumoured to be penning a comedy with best pal Amy Schumer.
Looks like her schedule is full but according to recent confirmation by Deadline, she has signed on to play the character of Elizabeth Holmes in Adam McKay’s movie Theranos. Fresh from his Oscar success in The Big Short, Adam is now taking the revolutionary company Theranos and it’s owner’s story to the big screen. Jen has already played such a role in Joy in which she portrayed Joy Mangano as she started her mop business. Gary Sanchez Productions is producing with Sanchez producer Kevin Messick.
Elizabeth Holmes is the founder of the controversial biotech firm Theranos. The company was once one of Silicon Valley's most promising startups. Its multi-billion dollar valuation and promises of a blood testing system that claimed to be able to perform complex tests with just a drop of blood. The company was at one point worth $9 billion.
Theranos lost trust with the public after an investigation by The Wall Street Journal poked holes in its claims about its new blood testing system. It has been in decline ever since and the credibility of the company never recovered.